Analyst Research

Report Title Price
Wright Investors Service Comprehensive Report for Biotest AG
Provider: Wright Reports
$460.00
Buy
Biotest AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Biotest AG (BIO) - Financial and Strategic SWOT Analysis Review
Provider: GlobalData
$125.00
Buy
Biotest AG (BIO) - Medical Equipment - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Biotest AG First Drugmaker To Exit Greece-Reuters


Saturday, 16 Jun 2012 11:56pm EDT 

Reuters reported that Biotest AG would stop shipments to Greece in July, becoming the first drugmaker to announce it would quit the debt-mired country's market because its bills had not been paid. Though a relatively small player in Greece, the company's exit sets an unwelcome precedent for a country whose healthcare system is crumbling under the weight of economic crisis and administrative deadlock. 

Latest Developments for Biotest AG

Latest Key Developments in Biotechnology

Company Quote

Biotest AG
(BIOG.DE)
58.75
-0.5 -0.84%
24 May 2013